Pupillary response to light is preserved in the majority of patients undergoing rapid sequence intubation

Ann Emerg Med. 2011 Mar;57(3):234-7. doi: 10.1016/j.annemergmed.2010.10.017. Epub 2011 Jan 8.

Abstract

Study objective: We determine whether pharmacologic neuromuscular blockade with succinylcholine or rocuronium during emergency rapid sequence intubation affects pupillary response to light.

Methods: This was a prospective case series of patients undergoing rapid sequence intubation between February 2008 and February 2009. Two blinded, independent emergency physicians assessed pupillary response after administration of neuromuscular blockade and intubation. Cases without pupillary response before rapid sequence intubation were excluded. The primary outcome measure was clinically observable pupillary response.

Results: We studied 94 patients undergoing rapid sequence intubation, including 67 (71%) receiving succinylcholine and 27 (31%) receiving rocuronium. Of patients receiving succinylcholine, 61 of 67 (91%; 95% confidence interval 82% to 97%) demonstrated pupillary response after rapid sequence intubation. All patients receiving rocuronium demonstrated preserved pupillary reflexes. κ For interobserver agreement was 0.66.

Conclusion: Succinylcholine and rocuronium do not appear to inhibit pupillary response in patients undergoing emergency department rapid sequence intubation.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Androstanols / adverse effects*
  • Androstanols / therapeutic use
  • Emergency Service, Hospital
  • Female
  • Humans
  • Intubation, Intratracheal* / adverse effects
  • Intubation, Intratracheal* / methods
  • Male
  • Middle Aged
  • Neuromuscular Nondepolarizing Agents / adverse effects*
  • Neuromuscular Nondepolarizing Agents / therapeutic use
  • Prospective Studies
  • Reflex, Pupillary / drug effects*
  • Rocuronium
  • Succinylcholine / adverse effects*
  • Succinylcholine / therapeutic use

Substances

  • Androstanols
  • Neuromuscular Nondepolarizing Agents
  • Succinylcholine
  • Rocuronium